Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Author(s) -
Yongjun Wang,
Xia Meng,
Anxin Wang,
Xuewei Xie,
Yuesong Pan,
S. Claiborne Johnston,
Hao Li,
Philip M. Bath,
Qiang Dong,
Chunxue Wang,
Jing Jing,
Jinxi Lin,
Siying Niu,
Yilong Wang,
Xingquan Zhao,
Zixiao Li,
Yong Jiang,
Wei Li,
Liping Liu,
Jie Xu,
Liguo Chang,
Lihua Wang,
Xianbo Zhuang,
Jinguo Zhao,
Yefang Feng,
Honghao Man,
Guozhong Li,
Baojun Wang
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2111749
Subject(s) - ticagrelor , clopidogrel , cyp2c19 , medicine , stroke (engine) , cardiology , aspirin , physics , cytochrome p450 , metabolism , thermodynamics
Comparisons between ticagrelor and clopidogrel for the secondary prevention of stroke in CYP2C19 loss-of-function carriers have not been extensively performed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom